title: S-adenosylmethionine metabolism and liver disease.
abstract: Methionine is an essential amino acid that is metabolized mainly by the liver where it is converted to S-adenosylmethionine (SAMe) by the enzyme methionine adenosyltransferase. Although all mammalian cells synthesize SAMe, the liver is where the bulk of SAMe is generated as it is the organ where about 50% of all dietary methionine is metabolized. SAMe is mainly needed for methylation of a large variety of substrates (DNA, proteins, lipids and many other small molecules) and polyamine synthesis, so if the concentration of SAMe falls below a certain level or rises too much the normal function of the liver will be also affected. There are physiological conditions that can affect the hepatic content of SAMe. Consequently, to control these fluctuations, the rate at which the liver both synthesizes and catabolizes SAMe is tightly regulated. In mice, failure to do this can lead to fatty liver disease and to the development of hepatocellular carcinoma (HCC). Therefore, maintaining SAMe homeostasis may be a therapeutic target in nonalcoholic steatohepatitis, alcoholic- and non-alcoholic liver cirrhosis, and for the chemoprevention of HCC formation.
authors: CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. director@cicbiogune.com
authors: José M
authors: JM
authors: Mato
authors: M Luz
authors: ML
authors: Martínez-Chantar
authors: Shelly C
authors: SC
authors: Lu
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D005234:Fatty Liver / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008104:Liver Cirrhosis, Alcoholic / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy / Q000378:metabolism*; D008113:Liver Neoplasms / Q000378:metabolism; D065626:Non-alcoholic Fatty Liver Disease; D012436:S-Adenosylmethionine / Q000378:metabolism* / Q000627:therapeutic use
chemical_list: D012436:S-Adenosylmethionine
references: Hepatology. 2009 Aug;50(2):462-71
references: 19444874
references: Am J Clin Nutr. 2007 Jan;85(1):19-25
references: 17209172
references: Anticancer Res. 1991 Jul-Aug;11(4):1617-24
references: 1684097
references: Cell. 2011 Nov 11;147(4):840-52
references: 22035958
references: Biochem J. 2007 Jan 1;401(1):87-96
references: 16953798
references: Hepatology. 2011 Dec;54(6):1975-86
references: 21837751
references: Hepatology. 2008 Apr;47(4):1191-9
references: 18318442
references: Hepatology. 2010 Mar;51(3):734-6
references: 20198627
references: Physiol Rev. 2012 Oct;92(4):1515-42
references: 23073625
references: Carcinogenesis. 1985 Dec;6(12):1713-20
references: 2866045
references: J Hepatol. 1999 Jun;30(6):1081-9
references: 10406187
references: Mol Genet Metab. 2010 Oct-Nov;101(2-3):172-7
references: 20675163
references: Hepatology. 2012 Sep;56(3):982-93
references: 22407595
references: FASEB J. 2002 Aug;16(10):1292-4
references: 12060674
references: Carcinogenesis. 1995 Feb;16(2):427-30
references: 7859377
references: FASEB J. 2000 Dec;14(15):2511-8
references: 11099469
references: Mol Cell Proteomics. 2011 Jan;10(1):M110.000976
references: 20930037
references: J Nutr Biochem. 1990 May;1(5):228-37
references: 15539209
references: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5560-5
references: 11320206
references: J Hepatol. 2000 Dec;33(6):907-14
references: 11131452
references: Cancer Res. 1992 Sep 15;52(18):4979-86
references: 1516054
references: Metabolism. 1975 Jun;24(6):721-35
references: 1128236
references: Hepatology. 1988 Jan-Feb;8(1):65-8
references: 3338721